What is one potential benefit of using therapeutic cloning?

Therapeutic cloning involves creating embryonic stem cells with the potential to develop into various types of tissues. This process can lead to significant advancements in regenerative medicine, particularly in the development of tissues for organ transplantation. The cells produced through therapeutic cloning can be engineered to match a patient's own genetic makeup, thus minimizing the risk of organ rejection and offering a solution to the shortage of available organs for transplant.

By enabling the growth of tissues specifically tailored to individual patients, therapeutic cloning holds the promise of treating a variety of conditions, including degenerative diseases, injuries, and organ failures. This tailored approach enhances the potential for successful transplants and improves the overall outcomes for patients requiring organ replacement.

Other options, such as the creation of designer babies with preferred traits, enhancement of genetic diversity, and the improvement of artificial reproductive techniques, do not align directly with the primary aim of therapeutic cloning, which is focused on medical treatment and tissue regeneration rather than these broader genetic or reproductive goals.